And guys would benefit from paying attention to their skin cancer risk. “The truth is that, in aggregate, men just don’t take ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

The KEYNOTE-689 study showed pembrolizumab with standard of care significantly improved outcomes for resectable HNSCC, ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Hamad Medical Corporation (HMC) hosted its inaugural Patient Awareness Programme, “Enhancing the Quality of Life of Patients ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.